LINDSAY HAMMETT: Open Payments
NPI 1851656078 · AIKEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 58 payments from 17 companies in 2025. Trend: 2023 $1,484 · 2024 $1,364 · 2025 $1,061
Food & beverage: $1,061
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $145 |
| AstraZeneca Pharmaceuticals LP | 5 | $143 |
| Lilly USA, LLC | 6 | $120 |
| Novo Nordisk Inc | 5 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $102 |
| PFIZER INC. | 4 | $83 |
| Corcept Therapeutics | 4 | $80 |
| Abbott Laboratories | 3 | $56 |
| Boston Scientific Corporation | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
Products named: Kerendia, MOUNJARO, FARXIGA, NURTEC ODT, QULIPTA, Korlym, FREESTYLE LIBRE 3, Ozempic.
Industry payments across SC — which companies pay providers there.
